Vita Leonardi
Palermo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
A Multicenter Real-Life Evaluation of Safety and Effectiveness of the Antibody-Drug Conjugate Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
Journal: American journal of clinical oncology
Published: May 19, 2025
Trastuzumab plus lapatinib or chemotherapy in patients with HER2-overexpressed advanced breast cancer: a randomized, phase II trial (GIM12-TYPHER).
Journal: The oncologist
Published: January 25, 2025
Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients.
Journal: Scientific reports
Published: April 06, 2023
Unmet Nutritional and Psychological Needs of Cancer Patients: An Integrated Multi-Professional Model Approach.
Journal: Diseases (Basel, Switzerland)
Published: June 26, 2022
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study.
Journal: Breast cancer research and treatment
Published: August 13, 2021
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9).
Journal: Breast cancer research and treatment
Published: May 11, 2021
Non-surgical treatment of lower eyelid fat pads with an injectable solution acid deoxycholic based.
Journal: Journal of biological regulators and homeostatic agents
Published: May 20, 2020
Evaluation of the effectiveness and safety of peppermint peel (PMP) soft peeling for skin ageing.
Journal: Journal of biological regulators and homeostatic agents
Published: May 20, 2020
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study.
Journal: Breast (Edinburgh, Scotland)
Published: March 05, 2019
The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer.
Journal: Clinical breast cancer
Published: January 07, 2019
T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: April 30, 2018
Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?
Journal: Future oncology (London, England)
Published: November 29, 2017
Last Updated: 09/26/2026